Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Semini Sumanasuriya1,2, Aurelius Omlin3, Andrew Armstrong4, Gerhardt Attard1,2, Kim N. Chi5, Charlotte L. Bevan6, Aki Shibakawa6, Maarten J. IJzerman7, Bram De Laere8, Martijn Lolkema9, David Lorente10, Jun Luo11, Niven Mehra12, David Olmos13, Howard Scher14, Howard Soule15, Nikolas H. Stoecklein16, Leon W.M.M. Terstappen7, David Waugh17, Johann S. de Bono1,2
1Institute of Cancer Research, Sutton, UK
2The Royal Marsden Hospital NHS Trust, London, UK
3Cantonal Hospital St. Gallen, St. Gallen, Switzerland
4Duke Cancer Institute, Duke University, Durham, NC, USA
5BC Cancer Agency, Vancouver, BC, Canada
6Imperial College London, London, UK
7University of Twente, Twente, The Netherlands
8Centre for Oncological Research, University of Antwerp, Antwerp, Belgium
9Erasmus MC Cancer Institute, Rotterdam, the Netherlands
10Servicio Oncologia Medica Hospital Universitario La Fe, Valencia, Spain
11James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
12Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
13Spanish National Cancer Research Centre, Madrid, Spain
14Memorial Sloan-Kettering Cancer Center, New York, NY, USA
15Prostate Cancer Foundation, Santa Monica, CA, USA
16University Hospital and Medical Faculty of the Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
17Queen’s University Belfast, Belfast, UK
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European urology oncology
Tập 1
151-159
Thông tin tác giả